Advertisement

Topics

The Rumbaugh-Goodwin Institute for Cancer Research, Inc Company Profile

07:03 EST 14th December 2018 | BioPortfolio

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a not-for-profit research organization founded by Dr. James Reyniers in 1959. Historically, the genesis of RGI was through the LOBUND Institute of the University of Notre Dame, where Dr. Reyniers developed barrier-containment technology. This advance enabled the breeding of small germ-free animals with eventual application of the plastic bubble for immunodeficient patients.
Dr. Reyniers left Notre Dame in 1959 to establish the Germfree Life Research laboratories in Tampa, Florida. For the next ten years they concentrated on understanding the relationship of viruses to cancer. Rapid development of knowledge in the field of tumor immunology resulted in the laboratories refocusing their efforts on the role of immune factors in spontaneous leukemias, mammary tumors, and autoimmune diseases such as multiple sclerosis. The facility subsequently relocated to Fort Lauderdale, Florida, in 1969, where it was renamed the Leo Goodwin Institute for Cancer Research. There, in response to the National Cancer Act of 1971, the Institute established barrier-containment rooms which, under contract with National Cancer Institute, provided large numbers of specific pathogen-free rodents to research laboratories

Location

1850 NW 69th Ave Suite 5
Plantation
Florida
33313
United States of America

Contact

Phone: (954) 587-9020
Email: info@rgicr.org


News Articles [4778 Associated News Articles listed on BioPortfolio]

Ludwig Cancer Research and Cancer Research Institute launch cancer clinical trial

(Ludwig Institute for Cancer Research) Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimen...

La Jolla Institute receives $ 4.5 mill Cancer Moonshot award

(La Jolla Institute for Allergy and Immunology) Researchers at La Jolla Institute for Immunology (LJI) and UC San Diego have been awarded $ 4.5 million as part of the National Cancer Institute's Cance...

Goodwin Bio, Radimmune Enter Oncology Pact

Radimmune selected Goodwin for process development through cGMP manufacturing of their IgG mAb conjugate

La Jolla Institute receives $ 4.5 million Cancer Moonshot award

(La Jolla Institute for Allergy and Immunology) Researchers at La Jolla Institute for Immunology (LJI) and UC San Diego have been awarded $ 4.5 million as part of the National Cancer Institute's Cance...

Salk Institute researchers win five competitive grants for cancer research

(Salk Institute) Salk Institute scientists Ronald Evans, Diana Hargreaves, Tony Hunter, Graham McVicker and Geoffrey Wahl are among the first wave of researchers to receive funding from Padres Pedal t...

Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces

(Cancer Research UK) A 'rule book' to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cance...

Scientist earns third concurrent National Cancer Institute grant to study breast cancer

(Virginia Tech) Deb Kelly, an associate professor at the Virginia Tech Carilion Research Institute, was awarded $2.1 million by the National Cancer Institute (NCI) to study the protein that gives rise...

Newcastle University Secures Drug Development Funding

Newcastle University's Northern Institute for Cancer Research has been awarded £5m to bring more cancer drugs to clinical trials. The Cancer Research UK funding will be received over five years...

PubMed Articles [7711 Associated PubMed Articles listed on BioPortfolio]

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study.

The Institute of Medicine has called for approaches to help maximize the return on investments (ROI) in cancer clinical trials. Value of Research (VOR) is a health economics technique that estimates R...

Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop.

As part of the ongoing efforts to address the lack of clinical research on older adults with cancer, the American Society of Clinical Oncology (ASCO) and the US Food and Drug Administration cosponsore...

Attitudes to Brexit: A Survey of Nursing and Midwifery Students.

In a referendum on 23nd June 2016 the people of the UK voted to leave the European Union (EU). The phenomenon known as Brexit did not come out of nowhere: according to Clarke, Whiteley and Goodwin (20...

Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality.

Research progress in diseases of the exocrine pancreas [chronic pancreatitis (CP), pancreatogenic diabetes mellitus, and pancreatic cancer] has been hampered by the disorders' heterogeneity, the limit...

Cancer care and public health policy evaluations in France: Usefulness of the national cancer cohort.

In the context of the national Cancer Plans of France that have changed the healthcare landscape, it has become necessary to better document and assess the related actions, and to promote research and...

Clinical Trials [11648 Associated Clinical Trials listed on BioPortfolio]

Multidrug Resistance Proteins in Patients Enrolled in Clinical Trials Outside of the National Cancer Institute Center for Cancer Research

RATIONALE: Studying samples of tumor tissue or blood from patients with cancer in the laboratory may help doctors learn more about cancer and the development of multidrug resistance in pat...

Cancer Care in the National Cancer Institute Center for Cancer Research

This study provides cancer care through the National Cancer Institute's Medical Oncology Branch (MOB) to patients who are not enrolled in an active treatment research protocol. Patients re...

Addressing Prostate Cancer Information Disparities With eHealth Technology

his is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that wil...

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinico...

Evaluation and Treatment of People With Eye Diseases

This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye In...

Companies [3825 Associated Companies listed on BioPortfolio]

Goodwin Institute for Cancer Research

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a nonprofit cancer research facility dedicated to investigating and studying numerous types of cancer. Our goal is to find a cure or c...

The Rumbaugh-Goodwin Institute for Cancer Research, Inc

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a not-for-profit research organization founded by Dr. James Reyniers in 1959. Historically, the genesis of RGI was through the LOBUND ...

Goodwin Biotechnology, Inc

Goodwin Biotechnology, Inc. ("GBI"), based in Plantation, Florida, is the earliest established and one of the most experienced contract manufacturing organizations (CMOs) serving the biopharmaceutical...

The Wistar Institute and Christiana Care Health System

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent ...

Goodwin Biotechnology Inc.

More Information about "The Rumbaugh-Goodwin Institute for Cancer Research, Inc" on BioPortfolio

We have published hundreds of The Rumbaugh-Goodwin Institute for Cancer Research, Inc news stories on BioPortfolio along with dozens of The Rumbaugh-Goodwin Institute for Cancer Research, Inc Clinical Trials and PubMed Articles about The Rumbaugh-Goodwin Institute for Cancer Research, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Rumbaugh-Goodwin Institute for Cancer Research, Inc Companies in our database. You can also find out about relevant The Rumbaugh-Goodwin Institute for Cancer Research, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...


Corporate Database Quicklinks



Searches Linking to this Company Record